Acuta Capital Partners’s Verastem VSTM Stock Holding History
Bought
Maintained
Sold
Other funds holding VSTM
RI
DTC
AC
NCM
SCM
FCMV
Acuta Capital Partners's VSTM Position: Q1 2026 in Review
Acuta Capital Partners sold out of Verastem (VSTM) in Q1 2026, closing a stake of 143,446 shares — an estimated $1.11M sold.
Acuta Capital Partners first reported a position in VSTM in Q1 2020 and held it in 18 quarters. The position peaked at $9.5M in Q1 2020. 155 funds tracked by Wall St. Rank hold VSTM as of Q1 2026.
- Acuta Capital Partners reported no remaining Verastem position as of Q1 2026 after selling out during the quarter.
- Acuta Capital Partners sold 143,446 Verastem shares in Q1 2026, an estimated $1.11M.
- Acuta Capital Partners first reported a position in Verastem in Q1 2020 and held it in 18 quarters.
- Acuta Capital Partners's Verastem position peaked at $9.5M in Q1 2020.
- 155 funds tracked by Wall St. Rank held Verastem as of Q1 2026.
Based on Acuta Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.